摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-tert-butoxycarbonyl (-)-Geissman-Waiss lactone | 118462-78-5

中文名称
——
中文别名
——
英文名称
N-tert-butoxycarbonyl (-)-Geissman-Waiss lactone
英文别名
tert-butyl (3aS,6aS)-2-oxo-3a,5,6,6a-tetrahydro-3H-furo[3,2-b]pyrrole-4-carboxylate
N-tert-butoxycarbonyl (-)-Geissman-Waiss lactone化学式
CAS
118462-78-5
化学式
C11H17NO4
mdl
——
分子量
227.26
InChiKey
STOSVFIZVJTPBI-YUMQZZPRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.82
  • 拓扑面积:
    55.8
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Expedient syntheses of (+)-cis-(2R,3S)-3-hydroxyproline and (–)-(1S,5S)-2-oxa-6-azabicyclo[3.3.0]octan-3-one (the Geissman–Waiss lactone): formal enantioselective syntheses of (–)-retronecine and related pyrrolizidine alkaloids
    作者:Jeremy Cooper、Peter T. Gallagher、David W. Knight
    DOI:10.1039/c39880000509
    日期:——
    (6)(diastereoisomeric excess > 99%cis; enantiomeric excess, e.e., 80%); subsequent hydrolysis and crystallisation gives (+)-cis-(2R,3S)-3-hydroxyproline (7)(93% e.e.) which has been homologated to the bicyclic lactones (10) and (11), precursors of ()-retronecine, (+)-platynecine, ()-croalbinecine and related pyrrolizidines.
    酵母还原酮脯氨酸(5)得到羟基脯氨酸衍生物(6)(非对映异构体过量> 99%顺式;对映异构体过量,ee,80%);和(对映体过量,ee,80%)。随后水解和结晶,得到(+)-顺式-(2 R,3 S)-3-羟基脯氨酸(7)(93%ee),已与(-)的前体双环内酯(10)和(11)同源。 )-维甲酸,(+)-铂亚胺,(-)-croalbinecine和相关的吡咯嗪核苷。
  • Kouyama, Takafumi; Matsunaga, Hirofumi; Ishizuka, Tadao, Heterocycles, 1997, vol. 44, # 1, p. 479 - 486
    作者:Kouyama, Takafumi、Matsunaga, Hirofumi、Ishizuka, Tadao、Kunieda, Takehisa
    DOI:——
    日期:——
  • Asymmetric intramolecular Pd(II)-catalysed amidocarbonylation of unsaturated amino alcohols
    作者:Peter Koóš、Ivan Špánik、Tibor Gracza
    DOI:10.1016/j.tetasy.2009.10.024
    日期:2009.12
    The first example of an asymmetric carbonylative bicyclisation of racemic N-protected 1-amino-pent-4-ene-3-ols (+/-)-1 catalysed by palladium(II) with chiral bis(oxazoline) ligands was investigated. The kinetic resolution of (+/-)-1 in the presence of chiral catalyst, p-benzoquinone in acetic acid under carbon monoxide atmosphere afforded enantiomerically enriched derivatives of 2-oxa-6-azabicyclo[3.3.0]octan-3-ones (R,R)-2 and (S,S)-2, respectively. (C) 2009 Elsevier Ltd. All rights reserved.
  • Alternative Synthesis of (-)-Geissman-Waiss Lactone, a Key Intermediate of Necine Bases
    作者:Toshio Honda、Sae Matsumoto
    DOI:10.3987/com-05-s(k)29
    日期:——
    A facile synthetic route to (-)-Geissman-Waiss lactone, a key intermediate of necine bases, was established by employing ring closing metathesis (RCM), followed by intramolecular Michael reaction of the resulting a,p-unsaturated lactone, as the key steps.
  • COOPER, JEREMY;GALLAGHER, PETER T.;KNIGHT, DAVID W., J. CHEM. SOC. CHEM. COMMUN.,(1988) N 8, 509-510
    作者:COOPER, JEREMY、GALLAGHER, PETER T.、KNIGHT, DAVID W.
    DOI:——
    日期:——
查看更多

同类化合物

顺式-六氢呋喃并[3,4-C]吡咯 甲基4-甲基-4H-呋喃并[3,2-b]吡咯-5-羧酸酯 氮杂环丁烷并[1,2-a]呋喃并[2,3-c]吡咯 夫沙瑞汀A 呋喃并吡咯甲酸 六氢-1H-呋喃并[3,4-c]吡咯 六氢-1H-呋喃并[3,4-C]吡咯 八氢-呋喃并[3,2-c]吡啶 乙基4,6-二氢-5H-呋喃并[2,3-c]吡咯-5-羧酸酯 6H-呋喃并[2,3-b]吡咯-5-羧酸甲酯 6-甲基-6H-呋喃并[2,3-b]吡咯-5-羧酸 6-甲基-6H-呋喃并[2,3-b]吡咯-5-甲酰肼 4H-呋喃并[3,2-b]吡咯-5-羧酸乙酯 4H-呋喃并[3,2-b]吡咯-5-羧酸,2-甲酰基-,甲基酯 4H-呋喃并[3,2-b]吡咯 4H-呋喃并[3,2-B!吡咯-5-羧酸甲酯 4-甲基呋喃[3,2-b]吡咯-5-羧酸乙酯 4-甲基-4H-呋喃并[3,2-b]吡咯 4-甲基-4H-呋喃并[3,2-B]吡咯-5-甲酸 365-苄基六氢-1H-呋喃[34-c]吡咯 3-溴-4H-呋喃并[3,2-b]吡咯-5-羧酸 3-溴-4H-呋喃并[3,2-b]吡咯-5-甲酸乙酯 2-苯基-4H-呋喃并[3,2-b]吡咯-5-羧酸 2-甲酰基-6-甲基-6H-呋喃并[2,3-b]吡咯-5-羧酸 2-甲酰基-4-甲基-4H-呋喃并[3,2-b]吡咯-5-羧酸甲酯 2-甲基-4H-呋喃并[3,2-b]吡咯-5-羧酸甲酯 2-甲基-4H-呋喃并[3,2-b]吡咯-5-羧酸乙酯 2-甲基-4H-呋喃并[3,2-b]吡咯-5-羧酸 2-溴-4H-呋喃并[3,2-b]吡咯-5-羧酸乙酯 2-溴-4H-呋喃并[3,2-B]吡咯-5-羧酸 2-(4-甲氧基苯基)-4H-呋喃并[3,2-b]吡咯-5-羧酸乙酯 2-(4-甲氧基苯基)-4H-呋喃并[3,2-b]吡咯-5-羧酸 2,3,3A,4-四氢-5H-呋喃并[3,2-b]吡咯-5-酮 1-(4H-呋喃并[3,2-b]吡咯-4-基)乙酮 1-(2-甲基-4H-呋喃并[3,2-b]吡咯-4-基)乙酮 (9ci)-1-甲基-1H-呋喃并[3,4-b]吡咯-4,6-二酮 (4-甲基-4H-呋喃并[3,2-b]吡咯-5-基)甲醇 (3aR,6aR)-4-乙酰基六氢-2H-呋喃并[3,2-b]吡咯-2-酮 5-(3-chloropropyl)hexahydro-1H-furo[3,4-c]pyrrole Methyl 2-[2-cyano-2-(methoxycarbonyl)vinyl]-6-methoxyfuro[2,3-b]pyrrole-5-carboxylate Methyl 6-methoxymethyl-2-(3,3,6,6-tetramethyl-1(2H),8(7H)-dioxo-3,4,5,6-tetrahydro-9H-xanthen-9-yl)furo[2,3-b]pyrrole-5-carboxylate methyl 2-cyano-6-(methoxymethyl)furo[2,3-b]pyrrole-5-carboxylate Methyl 2-(2,2-dicyanovinyl)-6-methoxymethylfuro[2,3-b]pyrrole-5-carboxylate (1R,5S,1'S)-1,5-dimethyl-8-phenylethyl-2-oxa-8-azabicyclo[3.3.0]octane-3,7-dione (1S,5R,1'S)-1,5-dimethyl-8-phenylethyl-2-oxa-8-azabicyclo[3.3.0]octane-3,7-dione {3-[2-(4-chloro-phenyl)-6-oxo-4-thioxo-6H-1-oxa-3b,5-diaza-cyclopenta[a]pentalen-5-yl]-propyl}-phosphonic acid diethyl ester methyl 4-(3,4-dichlorobenzyl)-2-formylfuro[3,2-b]pyrrole-carboxylate (3aR,6aS)-5-benzyl-3a,6a-dimethyltetrahydro-1H-furo[3,4-c]pyrrole-1,3(3aH)-dione (1R,2R,6R,8R,15S)-10,14-aza-4,4-dimethyl-11-oxo-1-mesyloxy-3,5,7-trioxa-tetracyclo[7.6.0.02,6.010,15]pentadecane 5-methyl-1,3-bis(3-oxobutyl)dihydro-1H-furo[3,4-c]pyrrole-4,6(5H,6aH)-dione